PMC4361907_01
PET/CT scan with [18F]-fluorodeoxyglucose of hypermetabolic lytic vertebral lesions before (a) and after (b) 10 weeks of everolimus plus exemestane therapy.
cro-0008-0101-g01.jpg
PMC4361907_01_cro-0008-0101-g01.jpg
F1
After 10 weeks of therapy, PET/CT demonstrated diminished activity in all sites (fig. 1).